GlaxoSmithKline Consumer Healthcare Limited (GSKCH), makers of the 'Horlicks' brand of health drinks and foods, today posted a 15% growth in its net profit to Rs 110.6 crore in the quarter ended March 31, 2011.
"The quarter saw increased visibility across product portfolios supported by strong marketing initiatives. Both 'Horlicks' and 'Boost' powered ahead," GSKCH said in a statement.
During the quarter, the company's net sales increased by 9% to Rs 710 crore from Rs 648.43 crore posted in the same period last fiscal.
The company also manufactures and markets health drinks like 'Boost', 'Viva' and 'Maltova' besides a number of diverse products under brands like Eno, Crocin, and Iodex.
The company's advertising and promotional budget during the quarter increased to Rs 103.55 crore from Rs 98.24 crore spent in the year-ago period.
Shares of GSKCH closed at Rs 2,383.40 on the Bombay Stock Exchange, down 2.24% from the previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app